Induction of a MHC class I-restricted, CD8 positive cytolytic T-cell response by chimeric HIV-1 virus-like particles in vivo: implications on HIV vaccine development
- PMID: 7755506
Induction of a MHC class I-restricted, CD8 positive cytolytic T-cell response by chimeric HIV-1 virus-like particles in vivo: implications on HIV vaccine development
Abstract
New insights into HIV-pathogenesis suggest that the cell mediated immune response might play a crucial role in controlling HIV infection by suppressing HIV-replication in CD4-positive cells by a lymphokine-like soluble factor and by killing HIV-infected cells via classical CTL mediated lysis. This type of a cellular immune response rather than an antibody response seems to be most promising to protect if not from infection, so at least from disease. Therefore rationally designed candidate vaccines should be capable of inducing a cell mediated immunity in addition to a humoral immune response. In order to avoid adverse side effects upon immunization, carefully selected antigens and epitopes should be presented in a favourable manner to the immune system. In previous experiments, we could demonstrate that the gag-polyprotein precursor, known to include a series of T-helper and CTL epitopes, assembles to highly immunogenic, complete noninfectious HIV-1 virus-like particles (VLP). Based on these VLP we developed a novel antigen presentation system, which allows the presentation of selected epitopes derived from HIV reading frames other than gag to the immune system. Alternatively complete derivatives of the HIV-1 external glycoprotein can be presented by the VLP. Immunological analysis of different VLP preparations in a BALB/c mouse model revealed the induction of a strong CTL response. The significance of these observations for future vaccine strategies is discussed.
Similar articles
-
Development of HIV/AIDS vaccine using chimeric gag-env virus-like particles.Biol Chem. 1999 Mar;380(3):353-64. doi: 10.1515/BC.1999.047. Biol Chem. 1999. PMID: 10223338
-
Recombinant human immunodeficiency Pr55gag virus-like particles presenting chimeric envelope glycoproteins induce cytotoxic T-cells and neutralizing antibodies.Virology. 1997 Aug 18;235(1):26-39. doi: 10.1006/viro.1997.8668. Virology. 1997. PMID: 9300034
-
Construction, expression, and immunogenicity of chimeric HIV-1 virus-like particles.Virology. 1996 Jun 1;220(1):128-40. doi: 10.1006/viro.1996.0293. Virology. 1996. PMID: 8659105
-
Progress toward an artificial vaccine for HIV: identification of helper and cytotoxic T-cell epitopes and methods of immunization.Biotechnol Ther. 1991;2(1-2):123-35. Biotechnol Ther. 1991. PMID: 1726961 Review.
-
Virus-specific cytotoxic T lymphocyte responses in patients infected with the human immunodeficiency virus, HIV-1.Cell Mol Biol (Noisy-le-grand). 1994;40 Suppl 1:45-8. Cell Mol Biol (Noisy-le-grand). 1994. PMID: 7950861 Review.
Cited by
-
Lassa virus-like particles displaying all major immunological determinants as a vaccine candidate for Lassa hemorrhagic fever.Virol J. 2010 Oct 20;7:279. doi: 10.1186/1743-422X-7-279. Virol J. 2010. PMID: 20961433 Free PMC article.
-
Immunogenicity in Rabbits of Virus-Like Particles from a Contemporary Rabbit Haemorrhagic Disease Virus Type 2 (GI.2/RHDV2/b) Isolated in The Netherlands.Viruses. 2019 Jun 14;11(6):553. doi: 10.3390/v11060553. Viruses. 2019. PMID: 31207978 Free PMC article.
-
VLP-factory™ and ADDomer© : Self-assembling Virus-Like Particle (VLP) Technologies for Multiple Protein and Peptide Epitope Display.Curr Protoc. 2021 Mar;1(3):e55. doi: 10.1002/cpz1.55. Curr Protoc. 2021. PMID: 33729713 Free PMC article.
-
Virus like particle-based vaccines against emerging infectious disease viruses.Virol Sin. 2016 Aug;31(4):279-87. doi: 10.1007/s12250-016-3756-y. Epub 2016 Jul 11. Virol Sin. 2016. PMID: 27405928 Free PMC article. Review.
-
Virus-like particles-universal molecular toolboxes.Curr Opin Biotechnol. 2007 Dec;18(6):537-45. doi: 10.1016/j.copbio.2007.10.013. Curr Opin Biotechnol. 2007. PMID: 18083549 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical
Research Materials